Dec 16, 2024
Embryonal Subtype
Alveolar Subtype
Embryonal vs Alveolar RMS
Diagnosis
COG Risk Stratification for Rhabdomyosarcoma
Prognosis
It is a rare and aggressive soft tissue sarcoma. Other genetic syndromes associated with rhabdomyosarcoma are given below:
60% of childhood Rhabdomyosarcoma. Intermediate to good prognosis Head and neck, GU system
25%–40% of all Rhabdomyosarcoma. Poor prognosis, trunk, extremities.
Pleomorphic is an adult form—1-2% of the Rhabdomyosarcoma.
Also read: Neonatal Hypocalcemia
Cells are arranged loosely in edematous stroma. Variant called Sarcoma Botryoides (grape-like masses) Loss of heterozygosity of the 11p gene.
Alveoli likes patterns of arrangement. The fusion proteins (PAX3 FOXO-1 and PAX7 FOXO-1). They have a high incidence of translocation (1,13) (2,13).
Also read: Rare Cancers in Children
The clinical features are heterogeneous. Site of origin (most common): Head & Neck > GU > Extremities > Other parts.
1. Asymptomatic mass / swelling: Limbs—apparent after trauma
2. Obstructive symptoms: Airway → Obstruction, Middle ear → OM, Ear pain, CNS → CN palsies
3. Orbital RMS → Proptosis, Strabismans
4. Botryoid → “Bunch of grapes” Vagina/bladder/middle ear
5. Constitutional symptoms
6. Site of metastasis → Pulmonary: Sarcoma Botryoides (grape-like masses)
Two steps for diagnosing RMS: clinical suspicion and imaging, including CT scan, MRI, ultrasound, and PET. Biopsy- Gross appearance: alveolar or embryonic. Microscopy: small round blue cells with tadpole-like cells (myoblasts). Positive for muscle-specific markers like Desmin and actin.
Favourable sites: Female genital, male paratesticular, head and neck
T1: confined to site of origin; T2: Any spread or fixation of mass
Site a: <5 cm, size b: ≥5 cm
Stage | Site | T stage | Size | Node status | Metastasis |
1 | Favorable | T1 or T2 | a or b | N0 or N1 or Nx | M0 |
2 | Unfavorable | T1 or T2 | a | N0 or Nx | M0 |
3 | Unfavorable | T1 or T2 | ab | N1N0 or N1 or Nx | M0 |
4 | Any | T1 or T2 | a or b | N0 or N1 or Nx | M1 |
Also read: Langerhans Cell Histiocytosis in Children
Three groups are defined based on stage, histology, and group. The group is classified into low-risk, intermediate, and high-risk groups. Low risk: chemotherapy using vincristine, Actinomycin D, and ± cyclophosphamide.
Surgery: Surgery followed by radiotherapy can be given for residual disease. Intermediate risk: chemotherapy combined with three to four drugs (Vincristine, Actinomycin D, and Cyclophosphamide + Irinotecan) + radiotherapy. High risk has poor outcomes despite all the modalities.
Depends upon the stage or histology. Head and neck involvement, especially orbits, have good outcomes. Genital and urinary tract have good outcomes. Extremity tumors and alveolar histology have poor outcomes. If there is a residual disease after surgery followed by chemotherapy, poor outcome.
Also read: Neuroblastoma -Investigation, Staging and Treatment
Hope you found this blog helpful for your NEET SS Pediatrics Oncology preparation. For more informative and interesting posts like these, keep reading PrepLadder’s blogs.
Get access to all the essential resources required to ace your medical exam Preparation. Stay updated with the latest news and developments in the medical exam, improve your Medical Exam preparation, and turn your dreams into a reality!
The most popular search terms used by aspirants
Avail 24-Hr Free Trial